Semaglutide GLP-1, a key ingredient in medications like Wegovy, begins working to suppress appetite within a few days to weeks after starting treatment
It has the potential to offer numerous insights, including improved understanding of disease pathophysiology, delineation of mechanisms of action for current treatment strategies, development of biomarkers to predict treatment response and disease progression, and identification of novel therapeutic targets 7
Weeks 13-16: The Optimization Phase (1.7 mg) For those who tolerate the medication well and need additional weight loss support, the dose may increase to 1.7 mg weekly
Detoxes, extra water, or special foods do not speed up clearance
For some people, the nausea is mild and passes within a few hours
Tulsi is friendly, knowledgeable, and skilled